Lunch Session: Strategies for Improving Long-term Management of Hepatic Encephalopathy: Assessing Therapies for Secondary Prophylaxis
Jasmohan S. Bajaj, MBBS, MD, MS, FACG,AGAF, FAASLD
Associate Professor of Medicine
Division of Gastroenterology, Hepatology, and Nutrition
Virginia Commonwealth University and McGuire VA Medical Center
Jasmohan S. Bajaj, MBBS, MD, MS, is an Associate Professor of Medicine, Division of Gastroenterology, Hepatology, and Nutrition at Virginia Commonwealth University and McGuire VA Medical Center in Richmond, VA. He is a Fellow of the American Gastroenterological Association, American Association for the Study of Liver Disease and American College of Gastroenterology. He is also a member of the American Society for Clinical Investigation.
Dr. Bajaj earned his MBBS from Delhi University at Maulana Azad Medical College. He completed an internship in internal medicine at Delhi University at Maulana Azad Medical College and internal medicine residency at the State University of New York Health Science Center in Brooklyn. He furthered his medical training with a fellowship in gastroenterology and hepatology at the Medical College of Wisconsin Affiliated Hospitals, then went on to earn an MS in epidemiology at the Medical College of Wisconsin in Milwaukee.
Active in research, Dr. Bajaj has served as a principal investigator or co-investigator for numerous clinical trials in areas such as hepatic encephalopathy, chronic liver disease and microbiome. Dr Bajaj's research has been funded through the NIH, US Veterans Affairs and American College of Gastroenterology. His work has been published in Nature, Gastroenterology, Hepatology, the American Journal of Gastroenterology and Liver Transplantation, among others. Dr Bajaj is an Associate Editor for the American Journal of Gastroenterology and was on the editorial board for Alimentary Pharmacology and Therapeutics and Liver International. Dr. Bajaj frequently presents his work on hepatic encephalopathy and chronic liver disease nationally and internationally at meetings, grand rounds, and symposia and is a member of the Hepatic Encephalopathy Guidelines Writing Committee. He is also a member of several medical associations, including the American Gastroenterological Association, the American Association for the Study of Liver Disease, and the American College of Gastroenterology. Dr Bajaj is the Chairperson for the North American Consortium for Study of End-stage Liver Disease and the President-Elect for the International Society for the Study of Hepatic Encephalopathy and Nitrogen Metabolism.
November 5, 2016, 12:00 pm